Susan Wu has served as Executive Director, Corporate Strategy and COO since Oct 2019. Susan boasts over 12 years of experience in healthcare industry.
Before joining Reistone Biopharma, she worked in Prosnav Capital responsible for exploring oversea fund business in healthcare, med tech and TMT sectors in markets including Canada and Europe. Prior to that, Susan worked in GlaxoSmithKline for more than a decade in broad spectrum in both pharma and vaccine sectors including business development, sales management, marketing, pipeline development, portfolio strategy, scientific engagement and patient advocacy. Susan obtained B.S. diploma in chemistry, then M.S. in Chemometrics from Tongji University, and MBA degree from Cheung Kung Graduate School of Business.